Management of Patients with Interstitial Lung Disease in the Midst of the COVID-19 Pandemic

Affiliations

¹ Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, University General Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
² Division of Pulmonary, Sleep and Critical Care Medicine, University of Washington, Seattle, Washington, USA.
³ Athens Medical Center and 1st Department of Respiratory Medicine, "Sotiria" Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, Athens, Greece.
⁴ Athens Medical Center and 1st Department of Respiratory Medicine, "Sotiria" Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, Athens, Greece, dbouros@med.uoa.gr.

Editorial

Katerina M Antoniou et al. Respiration. 2020.

. 2020;99(8):625-627.

doi: 10.1159/000509523. Epub 2020 Aug 25.

¹ Laboratory of Molecular and Cellular Pneumonology, Department of Respiratory Medicine, University General Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.
² Division of Pulmonary, Sleep and Critical Care Medicine, University of Washington, Seattle, Washington, USA.
³ Athens Medical Center and 1st Department of Respiratory Medicine, "Sotiria" Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, Athens, Greece.
⁴ Athens Medical Center and 1st Department of Respiratory Medicine, "Sotiria" Hospital for Diseases of the Chest, National and Kapodistrian University of Athens, Athens, Greece, dbouros@med.uoa.gr.

No abstract available

Conflict of interest statement

The authors declare that they have no conflicts of interest to disclose.

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.
Wong AW, Fidler L, Marcoux V, Johannson KA, Assayag D, Fisher JH, Hambly N, Kolb M, Morisset J, Shapera S, Ryerson CJ. Wong AW, et al. Chest. 2020 Sep;158(3):1069-1078. doi: 10.1016/j.chest.2020.04.019. Epub 2020 Apr 22. Chest. 2020. PMID: 32333929 Free PMC article. Review.

1. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep;198((5)):e44–68. - PubMed
1. British Thoracic Society Advice for Managing Interstitial Lung Disease Patients during COVID-19 pandemic. https://brit-thoracic.org.uk/media/455101/bts-management-advice-for-ild-....
1. Halpin DM, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020 May;8((5)):436–8. - PMC - PubMed
1. Sweiss NJ, Korsten P, Syed HJ, Syed A, Baughman RP, Yee AM, et al. When the Game Changes: Guidance to Adjust Sarcoidosis Management During the COVID-19 Pandemic. Chest. 2020 Apr;S0012-3692((20)):30778–9. - PMC - PubMed
1. Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, et al. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J Autoimmun. 2020 May;109:102442. - PMC - PubMed